| Financial Year |
March 31 2023 |
| Monetary Funds |
141,074,163.49 |
| Held-for-trading Financial Assets |
69,574,215.53 |
| Notes Receivable |
409,387.30 |
| Accounts Receivable |
473,185,858.04 |
| Advances to Suppliers |
9,889,655.02 |
| Other Receivables |
2,305,828.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
757,601,565.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
135,449,874.56 |
| Total Current Assets |
1,706,955,490.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,753,403.84 |
| Investment Properties |
7,026,174.60 |
| Fixed Assetes |
76,744,257.34 |
| Under-construction Projects |
149,129,299.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,332,960.08 |
| R&D expenses |
-- |
| Goodwill |
100,207,841.94 |
| Long-Term Deferred and Prepaid Expenses |
6,061,175.02 |
| Deferred Income Tax Assets |
58,184,760.64 |
| Other Non-Current Assets |
9,551,041.62 |
| Sub-Total of Non-Current Assets |
495,245,569.69 |
| Total Assets |
2,202,201,059.83 |
| Short-Term Loans |
389,894,036.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,322,204.29 |
| Accounts Payable |
254,101,390.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,070,792.43 |
| Taxes Payable |
10,670,205.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,904,930.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,120,118.15 |
| Other Current Liabilities |
2,701,741.29 |
| Sub-Total of Current Liabilities |
860,440,030.56 |
| Long-term Loans |
25,465,302.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,032,433.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,397,566.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
65,686,629.64 |
| Total Liabilities |
926,126,660.20 |
| Paid-In Capital(Or Share Stock) |
210,508,200.00 |
| Capital Surplus |
501,701,442.22 |
| Surplus Reserve |
44,003,962.27 |
| LESS:Treasury Stock |
19,288,800.00 |
| Undistributed Profits |
508,354,925.71 |
| Minority Stockholder's Interest |
21,322,081.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,254,752,318.35 |
| Owner's Equity（Stockholder's Equity） |
1,276,074,399.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,202,201,059.83 |
